Laboratory Equipment

RSS | Random | Archive

About Me

An excellent international resource for the laboratory equipment industry.

Blogs I follow:

Theme by: Miguel
  1. Experts Question Price of New Hep C Drug

    An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences Inc.

    A panel of California medical experts voted that Gilead’s Sovaldi represents a “low value” treatment, considering its cost compared with older drugs for the blood-borne virus.

    Read more: http://www.laboratoryequipment.com/news/2014/03/experts-question-price-new-hep-c-drug

  2. 12 Notes
  3. Hawaii Warns Against Deadly Diet SupplementThe Hawaii Department of Health and federal agencies are warning the public to stop using a diet supplement and have asked retailers to take the product off the shelves after reports of hepatitis and liver failure around the state, including one death.The department, the U.S. Food and Drug Administration and the Centers of Disease Control have advised consumers to stop using OxyELITE Pro. The state is asking retailers to stop selling the product, and the manufacturer — USPlabs LLC, of Dallas — has informed the FDA that it will voluntary stop distributing OxyELITE Pro while the company cooperates with the investigation, according to the FDA.Read more: http://www.laboratoryequipment.com/news/2013/10/hawaii-warns-against-deadly-diet-supplement

    Hawaii Warns Against Deadly Diet Supplement

    The Hawaii Department of Health and federal agencies are warning the public to stop using a diet supplement and have asked retailers to take the product off the shelves after reports of hepatitis and liver failure around the state, including one death.

    The department, the U.S. Food and Drug Administration and the Centers of Disease Control have advised consumers to stop using OxyELITE Pro. The state is asking retailers to stop selling the product, and the manufacturer — USPlabs LLC, of Dallas — has informed the FDA that it will voluntary stop distributing OxyELITE Pro while the company cooperates with the investigation, according to the FDA.

    Read more: http://www.laboratoryequipment.com/news/2013/10/hawaii-warns-against-deadly-diet-supplement

  4. 11 Notes
  5. HCV Patients Go Untreated, Despite Effective Drugs

    Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Hospital Psychiatry. This is despite the availability of highly effective anti-viral drugs that clear hepatitis C virus in about 80 percent of patients participating in clinical trials. Major barriers to recommended care are substance abuse and depression in HCV patients.

    Other barriers to treatment include patients’ attitudes toward treatment, including a fear of the side effects associated with some of the anti-viral drugs and an inability or unwillingness to abstain from drugs or alcohol, which is required for successful treatment.

    Read more: http://www.laboratoryequipment.com/news/2012/12/hcv-patients-go-untreated-despite-effective-drugs

  6. 5 Notes
  7. Plasma Beats Potentially Lethal VirusesLife-threatening viruses such as HIV, SARS, hepatitis and influenza, could soon be combated in an unusual manner as researchers have demonstrated the effectiveness of plasma for inactivating and preventing the replication of adenoviruses. When exposed to plasma—the fourth state of matter in addition to solids, liquids and gases—for a period of just 240 seconds, it was found that only one in a million viruses could still replicate—practically all were inactivated.Read more: http://www.laboratoryequipment.com/news-Plasma-Kills-Potentially-Lethal-Viruses-120611.aspx

    Plasma Beats Potentially Lethal Viruses

    Life-threatening viruses such as HIV, SARS, hepatitis and influenza, could soon be combated in an unusual manner as researchers have demonstrated the effectiveness of plasma for inactivating and preventing the replication of adenoviruses. When exposed to plasma—the fourth state of matter in addition to solids, liquids and gases—for a period of just 240 seconds, it was found that only one in a million viruses could still replicate—practically all were inactivated.

    Read more: http://www.laboratoryequipment.com/news-Plasma-Kills-Potentially-Lethal-Viruses-120611.aspx

  8. 10 Notes